Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports
Highlights/Take-away message 1. The Chimpanzee Adenovirus-vectored Vaccine (ChAdOx1 nCoV-19 vaccine) has been widely used in Himalayan Country, Nepal and India. 2. Apart from other minor side effects, delayed thromboses in superficial vein have been reported after vaccination of ChAdOx1 nCoV-19 vacc...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-05-01
|
| Series: | Journal of Medical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13256-022-03407-6 |
| _version_ | 1811305093411110912 |
|---|---|
| author | Mukesh Kumar Sah Bishnu Mohan Singh Puja Sinha Prerit Devkota Sudhira Kumari Yadav John Shrestha Ashis Shrestha |
| author_facet | Mukesh Kumar Sah Bishnu Mohan Singh Puja Sinha Prerit Devkota Sudhira Kumari Yadav John Shrestha Ashis Shrestha |
| author_sort | Mukesh Kumar Sah |
| collection | DOAJ |
| description | Highlights/Take-away message 1. The Chimpanzee Adenovirus-vectored Vaccine (ChAdOx1 nCoV-19 vaccine) has been widely used in Himalayan Country, Nepal and India. 2. Apart from other minor side effects, delayed thromboses in superficial vein have been reported after vaccination of ChAdOx1 nCoV-19 vaccine and they may be the consequences of vaccination though larger study is needed to verify them. 3. Superficial vein thrombosis (SVT) should be an additional adverse effect to be mentioned in the list of adverse events associated with ChAdOx1 nCoV-19, Covishield, vaccine. 4. The benefits of the vaccine in breaking the chain of COVID 19 spread are certainly greater than the risk of thromboses. |
| first_indexed | 2024-04-13T08:19:01Z |
| format | Article |
| id | doaj.art-7de58dbf468a49e389b500ba467883fc |
| institution | Directory Open Access Journal |
| issn | 1752-1947 |
| language | English |
| last_indexed | 2024-04-13T08:19:01Z |
| publishDate | 2022-05-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Medical Case Reports |
| spelling | doaj.art-7de58dbf468a49e389b500ba467883fc2022-12-22T02:54:41ZengBMCJournal of Medical Case Reports1752-19472022-05-011611610.1186/s13256-022-03407-6Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reportsMukesh Kumar Sah0Bishnu Mohan Singh1Puja Sinha2Prerit Devkota3Sudhira Kumari Yadav4John Shrestha5Ashis Shrestha6Department of Emergency Medicine and General Practice, Patan Academy of Health SciencesPatan HospitalDepartment of Emergency Medicine and General Practice, Patan Academy of Health SciencesDepartment of Emergency Medicine and General Practice, Patan Academy of Health SciencesPublic Health Expert, Louisiana State UniversityPatan HospitalDepartment of Emergency Medicine and General Practice, Patan Academy of Health SciencesHighlights/Take-away message 1. The Chimpanzee Adenovirus-vectored Vaccine (ChAdOx1 nCoV-19 vaccine) has been widely used in Himalayan Country, Nepal and India. 2. Apart from other minor side effects, delayed thromboses in superficial vein have been reported after vaccination of ChAdOx1 nCoV-19 vaccine and they may be the consequences of vaccination though larger study is needed to verify them. 3. Superficial vein thrombosis (SVT) should be an additional adverse effect to be mentioned in the list of adverse events associated with ChAdOx1 nCoV-19, Covishield, vaccine. 4. The benefits of the vaccine in breaking the chain of COVID 19 spread are certainly greater than the risk of thromboses.https://doi.org/10.1186/s13256-022-03407-6ChAdOx1 nCoV-19Covishield vaccineSuperficial venous thrombosis (SVT)Venous thrombosisSuperficial saphenous vein (SSV)COVID 19 |
| spellingShingle | Mukesh Kumar Sah Bishnu Mohan Singh Puja Sinha Prerit Devkota Sudhira Kumari Yadav John Shrestha Ashis Shrestha Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports Journal of Medical Case Reports ChAdOx1 nCoV-19 Covishield vaccine Superficial venous thrombosis (SVT) Venous thrombosis Superficial saphenous vein (SSV) COVID 19 |
| title | Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports |
| title_full | Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports |
| title_fullStr | Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports |
| title_full_unstemmed | Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports |
| title_short | Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports |
| title_sort | superficial venous thrombosisas a possible consequence of chadox1 ncov 19 vaccine two case reports |
| topic | ChAdOx1 nCoV-19 Covishield vaccine Superficial venous thrombosis (SVT) Venous thrombosis Superficial saphenous vein (SSV) COVID 19 |
| url | https://doi.org/10.1186/s13256-022-03407-6 |
| work_keys_str_mv | AT mukeshkumarsah superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports AT bishnumohansingh superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports AT pujasinha superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports AT preritdevkota superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports AT sudhirakumariyadav superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports AT johnshrestha superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports AT ashisshrestha superficialvenousthrombosisasapossibleconsequenceofchadox1ncov19vaccinetwocasereports |